Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Analytics

Trial Phases

No phase data

Trial Status

Completed2

Role Distribution

Other Roles2

Activity Timeline

Clinical Trials (2)

NCT00665067Completed
Correlative Biomarker Study in Patients With Myeloproliferative Disorders
Essential ThrombocythemiaIdiopathic MyelofibrosisMyelofibrosis+2 more
Studychair
NCT00666549Completed
Research Tissue Bank
Essential ThrombocythemiaIdiopathic MyelofibrosisMyelofibrosis+1 more
Studychair

Research Network

Collaboration Network

22 collaborators·21 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Myeloproliferative Disorders-Research Consortium

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

John Mascarenhas, MD

Icahn School of Medicine at Mount Sinai

Moderately Similar
16 trials

Shared therapeutic areas:

Primary MyelofibrosisPolycythemia VeraThrombocythemia, Essential+1 more

Worked with same sponsors:

Icahn School of Medicine at Mount SinaiMyeloproliferative Disorders-Research Consortium+1 more
Collaborated on 1 trial
Similarity Score44%

Lewis Silverman, MD

Icahn School of Medicine at Mount Sinai

Moderately Similar
1 trials

Shared therapeutic areas:

Thrombocythemia, EssentialPrimary MyelofibrosisPolycythemia Vera

Worked with same sponsors:

Icahn School of Medicine at Mount SinaiMyeloproliferative Disorders-Research Consortium+1 more
Collaborated on 1 trial
Similarity Score34%

Ryotaro Nakamura

City of Hope Medical Center

Related
10 trials

Shared therapeutic areas:

Primary MyelofibrosisThrombocythemia, EssentialPolycythemia Vera

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score23%

Rami Komrokji, MD

H. Lee Moffitt Cancer Center and Research Institute

Related
5 trials

Shared therapeutic areas:

Thrombocythemia, EssentialPrimary MyelofibrosisPolycythemia Vera

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score23%

Ronald Hoffman, MD

Icahn School of Medicine at Mount Sinai

Related
10 trials

Shared therapeutic areas:

Primary MyelofibrosisPolycythemia VeraThrombocythemia, Essential

Worked with same sponsors:

Icahn School of Medicine at Mount SinaiMyeloproliferative Disorders-Research Consortium+1 more
Similarity Score23%

David Maloney

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Related
11 trials

Shared therapeutic areas:

Thrombocythemia, EssentialPolycythemia VeraPrimary Myelofibrosis

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score23%

Brenda Sandmaier

Fred Hutch/University of Washington Cancer Consortium

Related
7 trials

Shared therapeutic areas:

Thrombocythemia, EssentialPolycythemia VeraPrimary Myelofibrosis

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score23%

Josef T Prchal, MD

University of Utah

Related
6 trials

Shared therapeutic areas:

Primary MyelofibrosisThrombocythemia, EssentialPolycythemia Vera

Worked with same sponsors:

Myeloproliferative Disorders-Research ConsortiumNational Cancer Institute (NCI)
Similarity Score23%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Primary MyelofibrosisMyeloproliferative Disease

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Nina Bhardwaj, MD, PhD

Icahn School of Medicine at Mount Sinai

Related
8 trials

Shared therapeutic areas:

Thrombocythemia, EssentialPrimary Myelofibrosis

Worked with same sponsors:

Icahn School of Medicine at Mount SinaiNational Cancer Institute (NCI)
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT00665067StudyChair

Correlative Biomarker Study in Patients With Myeloproliferative Disorders

Essential ThrombocythemiaIdiopathic MyelofibrosisMyelofibrosis+2 more
Completed
NCT00666549StudyChair

Research Tissue Bank

Essential ThrombocythemiaIdiopathic MyelofibrosisMyelofibrosis+1 more
Completed

All 2 trials loaded